Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA
Shahrokh Javaheri
, Lee K. Brown
, William T. Abraham
,
Rami Khayat
Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
40
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Heart Failure
100%
Sleep-disordered Breathing
100%
Apnea
100%
Guided Therapy
100%
Patients with Heart Failure
100%
Randomized Controlled Trial
66%
Heart Failure with Preserved Ejection Fraction (HFpEF)
66%
Recent Advances
33%
Oxidative Stress
33%
Clinical Outcomes
33%
Improved Survival
33%
Patient Survival
33%
Sympathetic Activity
33%
High Prevalence
33%
Positive Airway Pressure Therapy
33%
Central Sleep Apnea
33%
Left Ventricular Ejection Fraction
33%
Oxidative Inflammation
33%
Left Ventricular Dysfunction
33%
Excess Mortality
33%
Heart Failure Treatment
33%
Repeated Hospitalization
33%
Symptomatic Patients
33%
Positive Airway Pressure
33%
Cardiovascular Consequences
33%
Medicine and Dentistry
Apnea
100%
Congestive Heart Failure
100%
Obstructive Sleep Apnea
50%
Randomized Controlled Trial
33%
Positive Airway Pressure
33%
Observational Study
16%
Prevalence
16%
Cardiovascular System
16%
Oxidative Stress
16%
Central Sleep Apnea
16%
Heart Left Ventricle Failure
16%
Heart Left Ventricle Ejection Fraction
16%
Heart Failure with Preserved Ejection Fraction
16%
Heart Failure with Reduced Ejection Fraction
16%
Biochemistry, Genetics and Molecular Biology
Breathing
100%
Randomized Controlled Trial
66%
Airway Pressure
66%
Oxidative Stress
33%
Prevalence
33%
Heart Left Ventricle Ejection Fraction
33%
Heart Ventricle Function
33%
Observational Study
33%
Heart Ejection Fraction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Apnea
100%
Sleep Disordered Breathing
50%
Randomized Controlled Trial
33%
Inflammation
16%
Prevalence
16%
Observational Study
16%
Heart Left Ventricle Failure
16%
Central Sleep Apnea Syndrome
16%
Heart Failure with Preserved Ejection Fraction
16%
Heart Failure with Reduced Ejection Fraction
16%
Agricultural and Biological Sciences
Obstructive Sleep Apnea
100%
Ejection Fraction
66%
Cardiovascular System
33%
Sole
33%
Observational Studies
33%
Pressure Treatment
33%
Oxidative Stress
33%
Central Sleep Apnea
33%
Neuroscience
Obstructive Sleep Apnea
100%
Randomized Controlled Trial
66%
Oxidative Stress
33%
Central Sleep Apnea
33%